Findings and insights from the genetic investigation of age of first reported occurrence for complex disorders in the UK Biobank and FinnGen
Feng, Y.-C. A.; Ge, T.; Cordioli, M.; FinnGen, ; Ganna, A.; Smoller, J.; Neale, B.
Show abstract
Age of onset contains information on the timing of events relevant to disease etiology, but there has not been a systematic investigation of its heritability from GWAS data. Here, we characterize the genetic architecture of age of first occurrence and its genomic relationship with disease susceptibility for a wide range of complex disorders in the UK Biobank. For diseases with a sufficient sample size, we discover that age of first occurrence has non-trivial genetic contributions, some with specific genetic risk factors not associated with susceptibility to the disease. Through genetic correlation analysis, we show that an earlier health-event occurrence is correlated with a higher polygenic risk of disease susceptibility. An independent genetic investigation of the FinnGen cohort replicates the pattern of heritability and genetic correlation estimates. We then demonstrate that incorporating disease onset age with susceptibility may improve genetic risk prediction and stratification.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Combining case-control status and family history of disease increases association power 96%
- Genome-wide analysis in 756,646 individuals provides first genetic evidence that ACE2 expression influences COVID-19 risk and yields genetic risk scores predictive of severe disease 96%
- Large scale genome-wide association study in a Japanese population identified 45 novel susceptibility loci for 22 diseases 96%
Similar papers in this journal
Similar papers in this journal
- Defining and Reducing Variant Classification Disparities 94%
- Genetic and non-genetic factors affecting the expression of COVID-19 relevant genes in the large airway epithelium 94%
- An atlas connecting shared genetic architecture of human diseases and molecular phenotypes provides insight into COVID-19 susceptibility 94%
Similar papers in this journal
- Proteome-wide Mendelian randomization in global biobank meta-analysis reveals multi-ancestry drug targets for common diseases 96%
- Analysis across Taiwan Biobank, Biobank Japan and UK Biobank identifies hundreds of novel loci for 36 quantitative traits 96%
- Incorporating family history of disease improves polygenic risk scores in diverse populations 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.